alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
#### State of Connecticut *v.*Andrew C. Kydes

The petition by the defendant for certification for appeal from the Appellate Division of the Circuit Court is granted.

*607
      *Charles Hanken,*in support of the petition.

*Dennis F. Gaffney,*assistant prosecuting attorney, in opposition.

Submitted September 27

decided October 23, 1968
Exhibit 35.5  LOGO

Commercial Mortgage Servicing
D1050-084, 8th Floor 401
South Tryon Street Charlotte, NC 28202 1-800-326-1334 ANNUAL STATEMENT OF COMPLIANCE Reference is hereby made to that certain Pooling and Servicing Agreement dated as of August 1, 2015, by and among DEUTSCHE MORTGAGE &
ASSET RECEIVING CORPORATION, as Depositor, WELLS FARGO BANK, NATIONAL ASSOCIATION, as Master Servicer, LNR PARTNERS, LLC, as Special Servicer, WILMINGTON TRUST, NATIONAL ASSOCIATION, as Trustee, and WELLS FARGO BANK, NATIONAL ASSOCIATION, as
Certificate Administrator, Paying Agent and Custodian, and PARK BRIDGE LENDER SERVICES LLC, as Operating Advisor with respect to Commercial Mortgage Pass-Through Certificates, COMM 2015-CCRE24 (the Agreement). Capitalized terms used
herein not otherwise defined shall have the meanings assigned in the Agreement. Pursuant to Section 10.11 of this Agreement, I,
Leslie Hayton, Managing Director of Commercial Mortgage Services do hereby certify that:  1.
A review of the activities of the Master Servicer during the period from January 1, 2018 through December 31,
2018 (the Reporting Period), and of its performance per the Agreement during such period has been made under my supervision, and  2.
To the best of my knowledge, based on such review, the Master Servicer has fulfilled all of its obligations
under the Agreement in all material respects throughout the Reporting Period. IN WITNESS WHEREOF, the undersigned has
executed this Certificate as of the 28th day of February 2019.  LOGOLeslie HaytonManaging DirectorWells Fargo Bank  Wells Fargo Bank, N.A.



LOGO
<PAGE>

                                                                    Exhibit 4.18
                                DEMAND DEBENTURE


February 7, 2003                                                CDN $600,000,000


The undersigned, 3351611 Canada Inc., a corporation existing under the laws of
Canada (the "CORPORATION"), for value received, hereby promises to pay to the
order of Bank of America, N.A. ("BA"), for its own benefit and on behalf and for
the benefit, and as holder of an irrevocable power of attorney ("FONDE DE
POUVOIR") under Article 2692 of the Civil Code of Quebec, of each of the other
Lenders (BA in the aforesaid capacities, the "AGENT") as defined in the Credit
Agreement (as defined below), ON DEMAND, at such address or addresses as the
Agent may designate at any time and from time to time by notice in writing to
the Corporation, upon presentation and surrender thereat of this Debenture, the
sum of SIX HUNDRED MILLION DOLLARS ($600,000,000) in lawful money of Canada, and
to pay interest thereon, before as well as after maturity and both before and
after default, from the date of this Debenture, at the same place, in like money
at a rate of TWENTY-FIVE PER CENT (25%) per annum from the date hereof, together
with interest on overdue interest (computed monthly) at the same rate from its
due date to the date of payment. This Debenture (a) is issued pursuant to the
provisions of the Credit Agreement, (b) is secured by a deed of hypothec made by
the Corporation in favour of the Agent and governed by the laws of the Province
of Quebec, and (c) is governed by the laws of the Province of Quebec.

Notwithstanding the fact that this Debenture is stated to be payable on demand,
payment of this Debenture may not be demanded until the occurrence of an Event
of Default (as defined in the Credit Agreement) which is continuing and which
has not been waived in accordance with the terms of the Credit Agreement.
Furthermore, notwithstanding the fact that this Debenture is in the amount of
$600,000,000 and bears interest at the rate of 25% per annum, the Corporation
shall not have any obligation, at any time, to make payment under this Debenture
for any amount in excess of its indebtedness under the Credit Documents then
outstanding.

"CREDIT AGREEMENT" means that certain credit agreement dated as of February 7,
2003 among Sun Media Corporation, as Borrower, the financial institutions named
on the signature pages thereto, as Lenders, and BA, as Administrative Agent, as
same may subsequently be amended, amended and restated, modified, supplemented
or replaced from time to time.

Capitalized terms not otherwise defined in this Debenture have the meaning
ascribed thereto in the Credit Agreement.

This Debenture may be transferred by the Agent only to a successor agent
appointed under and in accordance with the provisions of the Credit Agreement.





                               3351611 CANADA INC.





                             Per:  /s/ CLAUDINE TREMBLAY
                             ---------------------------
                             Name: Claudine Tremblay
                             Title: Assistant Secretary
```

[Congressional Bills 118th Congress]
[From the U.S. Government Publishing Office]
[H.R. 7893 Engrossed in House (EH)]

<DOC>
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
118th CONGRESS
  2d Session
                                H. R. 7893

_______________________________________________________________________

                                 AN ACT

 
 To designate the facility of the United States Postal Service located 
 at 306 Pickens Street in Marion, Alabama, as the ``Albert Turner, Sr. 
                        Post Office Building''.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. ALBERT TURNER, SR. POST OFFICE BUILDING.

    (a) Designation.--The facility of the United States Postal Service 
located at 306 Pickens Street in Marion, Alabama, shall be known and 
designated as the ``Albert Turner, Sr. Post Office Building''.
    (b) References.--Any reference in a law, map, regulation, document, 
paper, or other record of the United States to the facility referred to 
in subsection (a) shall be deemed to be a reference to the ``Albert 
Turner, Sr. Post Office Building''.

            Passed the House of Representatives June 3, 2024.

            Attest:

                                                                 Clerk.
118th CONGRESS

  2d Session

                               H. R. 7893

_______________________________________________________________________

                                 AN ACT

 To designate the facility of the United States Postal Service located 
 at 306 Pickens Street in Marion, Alabama, as the ``Albert Turner, Sr. 
                        Post Office Building''.
```
# C_2014292EN.01005002.xml

| 1.9.2014 | EN | Official Journal of the European Union | C 292/50 |
| --- | --- | --- | --- |

1.9.2014

EN

Official Journal of the European Union

C 292/50

---

Action brought on 24 June 2014 — Hewlett Packard Development Company v. OHIM (ELITEPAD)

(Case T-470/14)

2014/C 292/62

Language of the case: English

Parties

Parties

Applicant: Hewlett Packard Development Company LP (Houston, United States) (represented by: T. Raab and H. Lauf, lawyers)

Applicant:

Defendant: Office for Harmonisation in the Internal Market (Trade Marks and Designs)

Defendant:

Form of order sought

Form of order sought

The applicant claims that the Court should:

| — | Annul the decision of the Second Board of Appeal of the Office for Harmonisation in the Internal Market (Trade Marks and Designs) of 27 March 2014 in Case R 884/2013-2; |
| --- | --- |

—

Annul the decision of the Second Board of Appeal of the Office for Harmonisation in the Internal Market (Trade Marks and Designs) of 27 March 2014 in Case R 884/2013-2;

| — | Award the costs of the proceedings against the defendant. |
| --- | --- |

—

Award the costs of the proceedings against the defendant.

Pleas in law and main arguments

Pleas in law and main arguments

Community trade mark concerned: The word mark ‘ELITEPAD’ for goods in Class 9 Community trade mark application No 1 1 3 18  284

Community trade mark concerned:

Decision of the Examiner: The application was refused

Decision of the Examiner:

Decision of the Board of Appeal: The appeal was rejected

Decision of the Board of Appeal:

Pleas in law: Violation of Art. 7 (1) (c) and Art. 7 (2) of Regulation No 207/2009.

Pleas in law:

---
<PAGE>

EXHIBIT 32


                    CERTIFICATION OF CHIEF EXECUTIVE OFFICER
                       AND ACTING CHIEF FINANCIAL OFFICER
                       PURSUANT TO 18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


         In connection with the quarterly report on Form 10-Q of EMRISE
Corporation (the "Company") for the period ended March 31, 2006 (the "Report"),
the undersigned hereby certify in their capacities as Chief Executive Officer
and Chief Financial Officer of the Company, respectively, pursuant to 18 U.S.C.
section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of
2002, that:

         1. the Report fully complies with the requirements of Section 13(a) or
15(d) of the Securities Exchange Act of 1934, as amended; and

         2. the information contained in the Report fairly presents, in all
material respects, the financial condition and results of operations of the
Company.

Dated: January 17, 2007                       By: /s/ CARMINE T. OLIVA
                                                  ------------------------------
                                                  Carmine T. Oliva
                                                  Chief Executive Officer
                                                  (principal executive officer)


Dated: January 17, 2007                       By: /s/ CARMINE T. OLIVA
                                                  ------------------------------
                                                  Carmine T. Oliva
                                                  Acting Chief Financial Officer
                                                  (principal financial officer)

         A signed original of this written statement required by Section 906, or
other document authenticating, acknowledging, or otherwise adopting the
signatures that appear in typed form within the electronic version of this
written statement required by Section 906, has been provided to the Company and
will be retained by the Company and furnished to the Securities and Exchange
Commission or its staff upon request.
# C_2014303EN.01005501.xml

| 8.9.2014 | EN | Official Journal of the European Union | C 303/55 |
| --- | --- | --- | --- |

8.9.2014

EN

Official Journal of the European Union

C 303/55

---

Action brought on 17 July 2014 — Alsharghawi v Council

(Case T-532/14)

2014/C 303/65

Language of the case: French

Parties

Parties

Applicant: Bashir Saleh Bashir Alsharghawi (Johannesburg, South Africa) (represented by: É. Moutet, lawyer)

Applicant:

Defendant: Council of the European Union

Defendant:

Form of order sought

Form of order sought

The applicant claims that the Court should:

| — | Annul Decision 2011/137/CFSP and Decision 2011/178/CFSP; |
| --- | --- |

—

Annul Decision 2011/137/CFSP and Decision 2011/178/CFSP;

| — | Order the Council to pay the costs. |
| --- | --- |

—

Order the Council to pay the costs.

Pleas in law and main arguments

Pleas in law and main arguments

In support of the action, the applicant relies on four pleas in law.

| 1. | First plea in law, alleging that the Council had no power to include the applicant on the list of persons subject to restrictive measures, since the applicant’s name is not mentioned in the United Nations Security Council resolutions 1970 (2011) and 1973 (2011). |
| --- | --- |

1.

First plea in law, alleging that the Council had no power to include the applicant on the list of persons subject to restrictive measures, since the applicant’s name is not mentioned in the United Nations Security Council resolutions 1970 (2011) and 1973 (2011).

| 2. | Second plea in law, alleging infringement of the duty to state reasons, in so far as the Council merely relies on the abovementioned resolutions, without considering the applicant’s personal situation. |
| --- | --- |

2.

Second plea in law, alleging infringement of the duty to state reasons, in so far as the Council merely relies on the abovementioned resolutions, without considering the applicant’s personal situation.

| 3. | Third plea in law, alleging infringement of the applicant’s rights of defence and of the principle of the presumption of innocence as a result of the lack of an inter partes procedure. |
| --- | --- |

3.

Third plea in law, alleging infringement of the applicant’s rights of defence and of the principle of the presumption of innocence as a result of the lack of an inter partes procedure.

inter partes

| 4. | Fourth plea in law, alleging infringement of fundamental rights, in so far as, by imposing restrictive measures on the applicant, the Council unlawfully restricted his freedom of movement and his right to property. |
| --- | --- |

4.

Fourth plea in law, alleging infringement of fundamental rights, in so far as, by imposing restrictive measures on the applicant, the Council unlawfully restricted his freedom of movement and his right to property.

---
Editorial Note on Part 882
Editorial Note: Nomenclature changes to part 882 appear at 73 FR 35341, June 23, 2008.

§ 882.1560 Skin potential measurement device. ( a ) *Identification.* A skin potential measurement device is a general diagnostic device used to measure skin voltage by means of surface skin electrodes.
( b ) *Classification.* Class II (special controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 882.9.
[44 FR 51730, Sept. 4, 1979, as amended at 84 FR 71815, Dec. 30, 2019]
Exhibit 21

                           Subsidiaries of the Company

          Subsidiary                Jurisdiction of Organization
          ----------                ----------------------------

RF Power Components, Inc.                   New York
Anaren Power Products, Inc.                 Delaware
Anaren Microwave V.I., Inc.                 U.S. Virgin Islands
§ 884.1600 Transabdominal amnioscope (fetoscope) and accessories. ( a ) *Identification.* A transabdominal amnioscope is a device designed to permit direct visual examination of the fetus by a telescopic system via abdominal entry. The device is used to ascertain fetal abnormalities, to obtain fetal blood samples, or to obtain fetal tissue. This generic type of device may include the following accessories: trocar and cannula, instruments used through an operating channel or through a separate cannula associated with the amnioscope, light source and cables, and component parts.
( b ) *Classification.* Class III (premarket approval).
( c ) *Date premarket approval application (PMA) or notice of completion of a product development protocol (PDP) is required.* A PMA or a notice of completion of a PDP is required to be filed with the Food and Drug Administration on or before January 29, 1987 for any transabdominal amnioscope (fetoscope) and accessories that was in commercial distribution before May 28, 1976, or that has on or before January 29, 1987 been found to be substantially equivalent to a transabdominal amnioscope (fetoscope) and accessories that was in commercial distribution before May 28, 1976. Any other transabdominal amnioscope (fetoscope) and accessories shall have an approved PMA or a declared completed PDP in effect before being placed in commercial distribution.
[45 FR 12684, Feb. 26, 1980, as amended at 51 FR 39845, Oct. 31, 1986]
<TABLE> <S> <C>

<ARTICLE>     5
<LEGEND>  THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED
  FROM THE CONSOLIDATED BALANCE SHEET AS OF MARCH 29, 1997 AND THE
  CONSOLIDATED STATEMENT OF OPERATIONS FOR THE THREE MONTHS ENDED MARCH 29,
  1997 AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL
  STATEMENTS.
<MULTIPLIER>  1,000
       
<S>                                    <C>
<PERIOD-TYPE>                           3-MOS
<FISCAL-YEAR-END>                       JAN-03-1998
<PERIOD-END>                            MAR-29-1997
<CASH>                                    43,171 
<SECURITIES>                              16,500
<RECEIVABLES>                             63,587
<ALLOWANCES>                               6,362
<INVENTORY>                               61,484
<CURRENT-ASSETS>                         195,431
<PP&E>                                   111,728
<DEPRECIATION>                            66,852 
<TOTAL-ASSETS>                           254,541
<CURRENT-LIABILITIES>                     50,122
<BONDS>                                        0
<PREFERRED-MANDATORY>                          0
<PREFERRED>                                    0
<COMMON>                                      22
<OTHER-SE>                               201,136
<TOTAL-LIABILITY-AND-EQUITY>             254,541
<SALES>                                   85,425 
<TOTAL-REVENUES>                          85,425
<CGS>                                     62,187
<TOTAL-COSTS>                             62,187
<OTHER-EXPENSES>                               0
<LOSS-PROVISION>                           3,585
<INTEREST-EXPENSE>                           157
<INCOME-PRETAX>                            1,597
<INCOME-TAX>                                 543
<INCOME-CONTINUING>                        1,054 
<DISCONTINUED>                                 0
<EXTRAORDINARY>                                0
<CHANGES>                                      0
<NET-INCOME>                               1,054
<EPS-PRIMARY>                               0.05
<EPS-DILUTED>                               0.05  
        

</TABLE>
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE FORM
10-QSB FOR THE QUARTER ENDED JUNE 30, 2000 AND IS QUALIFIED IN ITS ENTIRETY BY
REFERENCE TO SUCH FORM 10-QSB.
</LEGEND>

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               JUN-30-2000
<CASH>                                       5,158,230
<SECURITIES>                                   882,273
<RECEIVABLES>                                1,138,834
<ALLOWANCES>                                         0
<INVENTORY>                                    713,959
<CURRENT-ASSETS>                             7,938,858
<PP&E>                                       7,206,975
<DEPRECIATION>                               2,404,952
<TOTAL-ASSETS>                              12,743,381
<CURRENT-LIABILITIES>                          633,861
<BONDS>                                      1,188,013
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                     6,509,267
<OTHER-SE>                                   4,148,567
<TOTAL-LIABILITY-AND-EQUITY>                12,743,381
<SALES>                                      4,560,008
<TOTAL-REVENUES>                             4,560,008
<CGS>                                        2,425,097
<TOTAL-COSTS>                                1,792,368
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                              46,386
<INCOME-PRETAX>                                609,044
<INCOME-TAX>                                   235,888
<INCOME-CONTINUING>                            373,156
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   373,156
<EPS-BASIC>                                        .09
<EPS-DILUTED>                                      .09


</TABLE>
§ 520.1265 Lincomycin and spectinomycin powder. ( a ) *Specifications.* The following salts of lincomycin and spectinomycin are present in a soluble powder in the ratio of 1 to 2 on the basis of equivalency of lincomycin base to equivalency of spectinomycin base: ( 1 ) Lincomycin hydrochloride monohydrate and spectinomycin sulfate tetrahydrate.
( 2 ) Lincomycin hydrochloride monohydrate and spectinomycin dihydrochloride pentahydrate.
( b ) *Sponsors.* See sponsors in § 510.600(c) of this chapter for use as in paragraph (d) of this section. ( 1 ) No. 054771 for use of product described in paragraph (a)(1) of this section.
( 2 ) Nos. 016592, 061133, and 066104 for use of product described in paragraph (a)(2) of this section.
( c ) *Tolerances.* See §§ 556.360 and 556.600 of this chapter.
( d ) *Conditions of use in chickens* — ( 1 ) *Amount.* 2 grams of antibiotic activity per gallon of drinking water; administer as the sole source of water for the first 5 to 7 days of life.
( 2 ) *Indications for use.* As an aid in the control of airsacculitis caused by either *Mycoplasma synoviae* or *M. gallisepticum* susceptible to lincomycin-spectinomycin and complicated chronic respiratory disease (air sac infection) caused by *Escherichia coli* and *M. gallisepticum* susceptible to lincomycin-spectinomycin.
( 3 ) *Limitations.* Federal law restricts this drug to use by or on the order of a licensed veterinarian.
[69 FR 13220, Mar. 22, 2004, as amended at 70 FR 40881, July 15, 2005; 71 FR 71038, Dec. 8, 2006; 77 FR 56770, Sept. 14, 2012; 78 FR 28823, May 20, 2014; 81 FR 94989, Dec. 27, 2016; 83 FR 48945, Sept. 28, 2018; 84 FR 8972, Mar. 13, 2019]
Editorial Note on Part 864
Editorial Note: Nomenclature changes to part 864 appear at 73 FR 35341, June 23, 2008.

§ 864.9195 Blood mixing devices and blood weighing devices. ( a ) *Identification.* A blood mixing device is a device intended for medical purposes that is used to mix blood or blood components by agitation. A blood weighing device is a device intended for medical purposes that is used to weigh blood or blood components as they are collected.
( b ) *Classification.* Class I (general controls). The manual device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to § 864.9.
[45 FR 60642, Sept. 12, 1980, as amended at 65 FR 2310, Jan. 14, 2000]